PBC Stock Chart & Stats
€0.08
>-€0.01(-1.32%)
At close: 4:00 PM EDT
€0.08
>-€0.01(-1.32%)
Day’s Range― - ―
52-Week Range€0.07 - €0.25
Previous CloseN/A
Volume0.00
Average Volume (3M)234.00
Market Cap
€22.72M
Enterprise Value€171.24
Total Cash (Recent Filing)€18.92M
Total Debt (Recent Filing)€0.00
Price to Earnings (P/E)―
Beta-0.39
Next Earnings
Aug 26, 2026Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.23
Shares Outstanding281,244,780
10 Day Avg. Volume40
30 Day Avg. Volume234
Financial Highlights & Ratios
PEG Ratio-0.07
Price to Book (P/B)1.38
Price to Sales (P/S)2.32
P/FCF Ratio274.27
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)<0.01
Revenue Forecast (FY)€8.17M
Bulls Say, Bears Say
Bulls Say
Balance Sheet StrengthA zero-debt, well-capitalized balance sheet provides durable financial flexibility: it reduces refinancing risk, supports multi-quarter investment in R&D and sales, and gives the company runway to pursue licensing deals or weather operating losses without immediate external financing.
High Gross Margins & Licensing ModelSustained ~73% gross margins reflect software licensing economics. Licensing of biometric matching tech to OEMs and integrators is structurally scalable, enabling incremental revenue with low incremental cost and providing a durable margin moat if product differentiation and partner embedment persist.
Positive Operating Cash FlowPositive operating cash flow in the TTM shows the core business can generate cash despite losses, improving short-to-medium term resilience. This operational cash provides funding for product development and customer support without immediate reliance on new equity or debt issuance.
Bears Say
Sustained Operating LossesLarge and persistent operating and net losses mean the company is not converting high gross margins into operating profit. Over months, continued negative margins can erode equity, limit reinvestment capacity, and necessitate external financing or structural cost/revenue changes to reach sustainable profitability.
Weak And Choppy Revenue TrendA declining, uneven revenue trajectory undermines visibility into demand and scale economics. Choppy top-line growth impedes the firm’s ability to leverage fixed costs, complicates partner and customer planning, and raises execution risk over the next 2–6 months absent stable, repeatable contract wins.
Volatile And Negative Free Cash FlowInconsistent free cash flow indicates operational and investment timing risks. Negative and volatile FCF reduces the company’s buffer against ongoing losses, increases probability of needing financing if losses persist, and makes long-term planning and sustained R&D or go-to-market spends more uncertain.
Precise Biometrics AB News
PBC FAQ
What was Precise Biometrics AB’s price range in the past 12 months?
Precise Biometrics AB lowest stock price was €0.07 and its highest was €0.25 in the past 12 months.
What is Precise Biometrics AB’s market cap?
Precise Biometrics AB’s market cap is €22.72M.
When is Precise Biometrics AB’s upcoming earnings report date?
Precise Biometrics AB’s upcoming earnings report date is Aug 26, 2026 which is in 25 days.
How were Precise Biometrics AB’s earnings last quarter?
Precise Biometrics AB released its earnings results on May 13, 2026. The company reported €0 earnings per share for the quarter, the consensus estimate of €0 by €0.
Is Precise Biometrics AB overvalued?
According to Wall Street analysts Precise Biometrics AB’s price is currently Overvalued.
Does Precise Biometrics AB pay dividends?
Precise Biometrics AB does not currently pay dividends.
What is Precise Biometrics AB’s EPS estimate?
Precise Biometrics AB’s EPS estimate is 0.
How many shares outstanding does Precise Biometrics AB have?
Precise Biometrics AB has 281,244,780 shares outstanding.
What happened to Precise Biometrics AB’s price movement after its last earnings report?
Precise Biometrics AB reported an EPS of €0 in its last earnings report, expectations of €0. Following the earnings report the stock price went down -0.8%.
Which hedge fund is a major shareholder of Precise Biometrics AB?
Currently, no hedge funds are holding shares in DE:PBC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Precise Biometrics AB
Precise Biometrics AB (publ) develops specialized software for reliably confirming individuals' identities across Europe, Asia, and the United States. Its product lineup includes Precise YOUNiQ, designed for digital identity verification; the BioMatch series, which comprises fingerprint algorithm solutions like BioMatch Card for secure authentication on smart cards and BioMatch Mobile for integration into smartphones and tablets; and Precise BioLive, a fingerprint software capable of detecting fake or spoofed fingerprints. The company's offerings are utilized by a wide range of clients, including sensor manufacturers, security companies, and system integrators, with applications spanning sectors such as finance, betting, healthcare, and transportation. Founded in 1997, Precise Biometrics AB (publ) is based in Lund, Sweden.